22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
All statements and expressions are the sole opinion of the Company and are subject to change without notice. The Company does not give investment advice and the Company is not liable for any investment decisions by any person or entity. It is strongly recommended that any purchase or sale decision relating to the Company’s common stock be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained in the Company’s website has been provided as an information service only. The completeness of the information is not warranted and is only as reliable as the sources from which it was obtained.
Information contained in the Company’s website contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as "expects", "will", "anticipates", "estimates", "believes", or by statements indicating certain actions "may", "could", "should" or "might" occur.